Cardinal Health Inc (CAH)
103.21
-0.60
(-0.58%)
USD |
NYSE |
Apr 26, 16:00
103.21
0.00 (0.00%)
After-Hours: 19:46
Cardinal Health SG&A Expense (Quarterly): 1.283B for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.283B |
September 30, 2023 | 1.197B |
June 30, 2023 | 1.267B |
March 31, 2023 | 1.179B |
December 31, 2022 | 1.191B |
September 30, 2022 | 1.197B |
June 30, 2022 | 1.155B |
March 31, 2022 | 1.137B |
December 31, 2021 | 1.151B |
September 30, 2021 | 1.114B |
June 30, 2021 | 1.129B |
March 31, 2021 | 1.12B |
December 31, 2020 | 1.147B |
September 30, 2020 | 1.137B |
June 30, 2020 | 1.137B |
March 31, 2020 | 1.165B |
December 31, 2019 | 1.163B |
September 30, 2019 | 1.107B |
June 30, 2019 | 1.165B |
March 31, 2019 | 1.097B |
December 31, 2018 | 1.064B |
September 30, 2018 | 1.155B |
June 30, 2018 | 1.271B |
March 31, 2018 | 1.132B |
December 31, 2017 | 1.131B |
Date | Value |
---|---|
September 30, 2017 | 1.062B |
June 30, 2017 | 983.00M |
March 31, 2017 | 960.00M |
December 31, 2016 | 910.00M |
September 30, 2016 | 920.00M |
June 30, 2016 | 970.00M |
March 31, 2016 | 914.00M |
December 31, 2015 | 922.00M |
September 30, 2015 | 842.00M |
June 30, 2015 | 847.00M |
March 31, 2015 | 803.00M |
December 31, 2014 | 815.00M |
September 30, 2014 | 775.00M |
June 30, 2014 | 795.00M |
March 31, 2014 | 736.00M |
December 31, 2013 | 766.00M |
September 30, 2013 | 732.00M |
June 30, 2013 | 776.00M |
March 31, 2013 | 712.00M |
December 31, 2012 | 699.00M |
September 30, 2012 | 690.00M |
June 30, 2012 | 711.00M |
March 31, 2012 | 683.00M |
December 31, 2011 | 640.00M |
September 30, 2011 | 644.00M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
1.107B
Minimum
Sep 2019
1.283B
Maximum
Dec 2023
1.165B
Average
1.155B
Median
Jun 2022
SG&A Expense (Quarterly) Benchmarks
McKesson Corp | 2.506B |
Cencora Inc | 1.399B |
Boston Scientific Corp | 1.379B |
DaVita Inc | 401.47M |
Elevance Health Inc | -- |